Altamira Therapeutics Ltd.: xbrl:AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables
| Value | {"unit": "CHF", "value": -146244} |
|---|---|
| Period | 2015-01-01 – 2015-12-31 |
| Status | current |
| Entity | Altamira Therapeutics Ltd. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T16:24:22.861909+02:00
Raw response sha256:
Cite as: FACTANKER, https://factanker.com/fact/95a59703-5e01-41db-80ae-b44e252875a6
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001601936-18-000007Retrieved: 2026-08-19T16:24:22.861909+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Cite as: FACTANKER, https://factanker.com/fact/95a59703-5e01-41db-80ae-b44e252875a6
History
- no predecessors — first report